Skip to main content

Breadcrumb

  1. Home

A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases

Submitted by Anonymous (not verified) on Mon, 02/05/2024 - 16:41
  • Read more about A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases

ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System

Submitted by Anonymous (not verified) on Mon, 02/05/2024 - 16:41
  • Read more about ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Submitted by Anonymous (not verified) on Mon, 02/05/2024 - 16:41
  • Read more about A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations

Submitted by Anonymous (not verified) on Wed, 01/17/2024 - 15:52
  • Read more about Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Submitted by Anonymous (not verified) on Wed, 01/17/2024 - 15:52
  • Read more about Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

Submitted by Anonymous (not verified) on Wed, 01/17/2024 - 15:52
  • Read more about A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

Submitted by Anonymous (not verified) on Wed, 01/17/2024 - 15:51
  • Read more about Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA-2

Submitted by Anonymous (not verified) on Mon, 01/08/2024 - 19:38
  • Read more about A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA-2

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

Submitted by Anonymous (not verified) on Mon, 01/08/2024 - 19:37
  • Read more about DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Submitted by Anonymous (not verified) on Mon, 01/08/2024 - 19:37
  • Read more about Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • Page 37
  • Page 38
  • …
  • Next page Next
  • Last page Last
Subscribe to